NMT's Non-Contact Medical Device Innovations - the Future of Patient Monitoring on the Battlefield, in Emergency Medical Situations and in Outer Space
LAS VEGAS, Dec. 9/PRNewswire/ -- Noninvasive Medical Technologies, Inc. (NMT), a medical device company pioneering highly advanced, award-winning medical assessment and communications solutions for military and civilian medical use, today announced that the Company has been awarded a sole source contract by the U.S. Air Force, valued at approximately $2.4 million, for continued development of the Multiple Casualty Assessment and Management System. Contracting activity is the Air Force Research Laboratory, Tyndall Air Force Base (contract number FA4819-09C-002).
Commenting on the award, Ronald McCaughan, Chairman and CEO of NMT, stated, "Our Company was originally challenged by the U.S. Air Force to develop a casualty assessment and management solution back in early 2006. This most recent award represents the fourth contract we've received from the Department of Defense and the third as a Department of Defense Prime Contractor with Sole Source Provider Designation. Moreover, it serves as a notable testament to NMT's engineering capabilities and to our team's proven ability to successfully meet and exceed crucial research and development milestones set for us by our Department of Defense partners."
The Multiple Casualty Assessment and Management System is a comprehensive, turnkey solution that incorporates NMT's patent-pending Etag(TM) - a non-contact hemodynamic monitoring device - with wireless communication, display technology and advanced tactile sensors to simultaneously detect and monitor multiple casualties within 300 yards of a medic or first response team. Remotely activated, the System monitors each individual casualty from point of wounding to casualty evacuation, and produces a necessary data record for follow-on casualty management. Further, the System provides a real time communications link with a rear tactical command center, enhancing command's battlefield situational awareness and supplying meaningful ground intelligence for required logistical response and follow-on care.
NMT is also currently engaged in adapting its innovative Etag technology for commercial use. Branded as the NcIQ(TM), market availability of this innovative device is currently pending review and clearance of a 510(k) submitted to the U.S. Federal and Drug Administration earlier this year. Once clearance is received by the FDA, NMT intends to pursue compelling market opportunities for the NcIQ that include applications in disaster response, underground coal mines, critical care facilities, firefighting, EMT/ambulance service and others.
According to Frost and Sullivan Research Analyst Zachary Bujnock, "While this system is pending FDA approval, it (NcIQ) has potential applications in many different kinds of emergency response. The use of complete non-contact monitoring is a perfect example of innovation, and in many ways is the future of patient monitoring, especially in remote settings."
NMT has also teamed with the National Aeronautics and Space Administration (NASA) on a joint research initiative involving parabolic investigations using the NcIQ device onboard Zero Gravity Corporation's modified Boeing 727 jet. More specifically, in association with NASA's FASTRACK project, the NcIQ is being used to perform continuous, noninvasive monitoring of human hemodynamics during changes in gravity. FASTRACK is a research platform created by NASA to enable its investigators to test experiments, apparatus and analytical techniques in hardware compatible with the International Space Station.
About Noninvasive Medical Technologies, Inc.
Headquartered in Las Vegas Nevada, Noninvasive Medical Technologies, Inc. (NMT) has pioneered a suite of highly advanced noninvasive medical assessment and communication tools and solutions that provide military and civilian medical care specialists with real-time situational awareness and critical life saving intelligence. NMT's mission is to save lives by continually advancing the standard for noninvasive patient monitoring across the care continuum, while maximizing clinical, medical and financial outcomes, and promoting scientific innovation. To learn more, please visit www.nmtinc.org.
FOR MORE INFORMATION, PLEASE CONTACT: Noninvasive Medical Technologies, Inc. Laura Dolajak, 888-466-8552 or via email at email@example.com OR Elite Financial Communication Group/Elite Media Group Dodi Handy, 407-585-1080 or via email at NMT@efcg.net
|SOURCE Noninvasive Medical Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved